Colgate-Palmolive Company (NYSE:CL) Upgrades/Downgrades review


Colgate-Palmolive Company (NYSE:CL) has a 1 Year Target Estimate of $76.56. The stock traded with the volume of 2.67 Million in the last trading session. Colgate-Palmolive Company opened at $66.65 and closed by showing an increase of 0.15%. The Bid price in the last session was $65.50 x 200 and the Ask price was $66.75 x 100. (The ask price is what sellers are willing to take for it. If you are selling a stock, you are going to get the bid price, if you are buying a stock you are going to get the ask price. The difference (or spread) goes to the broker/specialist that handles the transaction).

Colgate-Palmolive Company has the Market Capitalization of 59.13 Billion. The Stock has its 52-week High of $75.38 and 52-Week Low of $61.4 and it touched its 52-week high on Aug 12, 2016 and 52-Week Low on Jan 20, 2016.

Colgate-Palmolive Company reported its last Earnings on Oct 27 BMO where the company reported Actual EPS of $0.73/Share whereas, the Analyst Estimated EPS was $0.73/share. The difference between Actual EPS and Estimated EPS was $0/share. This represented an Earnings Surprise of 0%. The company will report its next earnings on 27-Jan-17.

Some analyst provided their insight on Growth Estimates; Colgate-Palmolive Company has the Current Quarter Earnings Growth rate of 4.1%. The Next Quarter growth is expected to be 12.7%. In the past 5 years, the stock has earnings growth rate of 1.6% per annum while the Upcoming 5 year’s earnings growth rate is expected to be 8.48% per annum.

16 number of analysts also provided their insight on Colgate-Palmolive Company, where the Average Price Target for the stock is $76.56. They also projected Low Price Target as $70 while High Price Target is set at $85.

A number of analysts rated the stock as well: 2 analysts believe that the stock is a STRONG BUY while 2 reported it as Buy.18 analysts assigned a HOLD rating, 0 said it’s UNDERPERFORM and 0 say that this stock is a SELL.

Colgate-Palmolive Company annual Divided is 1.56 while it’s Dividend Yield is 2.34%. The stock has its Price to Earnings (P/E) ratio of 43.54 and Forward Price to Earnings ratio of 21.81. The company has its Price to Sales (P/S) ratio of 3.85 where Price to Book (P/B) ratio of 0, Price to Cash Per share (P/C) of 39.79 and Price to Free Cash Flow (P/FCF) has a value of 57.92.

The company has its Return on Assets (ROA) of 11.1 Percent. Return on Equity (ROE) stands at -508.6% and Return on Investment (ROI) displays a value of 25.2%.

The stock is currently trading at Distance from 20-Day simple moving Average of -2.45% whereas, Distance from 50-Day Simple moving average is -5.69 Percent and Distance from 200-Day Simple Moving Average of -5.99 percent.

A look at performance overview of Colgate-Palmolive Company depicts that Performance (Week) is 0.47 percent while Performance Month is -6.52%. Quarterly performance shows a value of -10.21% and Half Year Performance value stands at -5.55%. Yearly performance of the stock has the value of 3.57 percent. Colgate-Palmolive Company has its YTD performance of 2.11 Percent. (YTD performance is the most important factor to consider; if YTD is negative, the stock is declining; if the YTD Performance value is Positive the stock is surging).

Insider Trades:

Many Insiders have done trades inside the company. The latest trade was made on 14 Nov 2016 where Chief Technology Officer Verduin (Patricia Ph.D.) did a transaction type “Buy” in which 3834 shares were traded at a price of $45.23. Another insider trade includes Chief Technology Officer Verduin (Patricia Ph.D.) who also initiated a transaction in which 3834 shares were traded on 14 Nov 2016 as “Sell”. On 16 Oct 2016 Chief Technology Officer Verduin (Patricia Ph.D.) traded 3834 shares as “Buy” at $45.23. Director Bilbrey (John P) Buy 256 shares on 2 Oct 2016 at the price of $73.08.

Upgrades/Downgrades Report:

The latest Upgrades/Downgrades was done by Research firm BofA/Merrill on 12-Sep-16 who Upgrade the stock from Neutral to Buy. Other firms have also Upgraded/Downgraded the stock. On 29-Jul-16, Exane BNP Paribas took an action “Downgrade” from Outperform to Neutral. On 2-May-16, the stock was Upgrade to Neutral by Goldman.